おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
NextCure
company
About
NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.
- 51 - 100
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $67M
- Industries
- Biopharma,Biotechnology,Health Care
- Founded date
- Jan 1, 2015
- Number Of Employee
- 51 - 100
- Operating Status
- Active
NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs. The Company is applying its proprietary platforms and know-how to identify novel and biologically relevant targets and develop first-in-class immunotherapy products.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$160M
NextCure has raised a total of
$160M
in funding over 2 rounds. Their latest funding was raised on
Nov 13, 2018 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 13, 2018 | Series B | $93M | 2 | — | — | Detail |
| Jan 6, 2016 | Series A | $67M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
NextCure is funded by 2 investors.
Pfizer
and Lilly Asia Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Pfizer
|
— | Series B |
Lilly Asia Ventures
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
